PA8584101A1 - Composicion antihelmintica e inyectable mejoradora de crecimiento - Google Patents

Composicion antihelmintica e inyectable mejoradora de crecimiento

Info

Publication number
PA8584101A1
PA8584101A1 PA20038584101A PA8584101A PA8584101A1 PA 8584101 A1 PA8584101 A1 PA 8584101A1 PA 20038584101 A PA20038584101 A PA 20038584101A PA 8584101 A PA8584101 A PA 8584101A PA 8584101 A1 PA8584101 A1 PA 8584101A1
Authority
PA
Panama
Prior art keywords
growth
improvement
injectable
antihelmintica
composition
Prior art date
Application number
PA20038584101A
Other languages
English (en)
Inventor
Vincent Beuvry
George Bufala
Guy Derrieu
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of PA8584101A1 publication Critical patent/PA8584101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES INYECTABLES QUE CONTIENEN UN SOLVENTE LIQUIDO SIN POLIMEROS SOLIDOS, AGENTE(S) ANTIHELMINTICOS(S) Y MEJORADOR(ES) DE CRECIMIENTO HORMONAL(ES), DONDE EL(LOS) AGENTE(S) ANTIHELMINTICOS(S) Y EL(LOS) MEJORADOR(ES) DE CRECIMIENTO HORMONAL(ES) SE DISUELVE(N) EN EL SISTEMA DE SOLVENTES SIN POLIMERO. LA PRESENTE INVENCION SE RELACIONA ADICIONALMENTE A LOS METODOS PARA MEJORAR EL CRECIMIENTO ANIMAL E INHIBIR LA INFECCION/PLAGA PARASITARIA CON ESTAS COMPOSICIONES, ASI COMO TAMBIEN LOS METODOS PARA PREPARAR TALES COMPOSICIONES.
PA20038584101A 2002-09-30 2003-09-30 Composicion antihelmintica e inyectable mejoradora de crecimiento PA8584101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/259,596 US6653288B1 (en) 2002-09-30 2002-09-30 Injectable anthelmintic compositions and methods for using same

Publications (1)

Publication Number Publication Date
PA8584101A1 true PA8584101A1 (es) 2004-05-21

Family

ID=29584164

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038584101A PA8584101A1 (es) 2002-09-30 2003-09-30 Composicion antihelmintica e inyectable mejoradora de crecimiento

Country Status (9)

Country Link
US (1) US6653288B1 (es)
CN (1) CN1684664A (es)
AU (1) AU2003274415A1 (es)
CO (1) CO5440227A1 (es)
EC (1) ECSP055710A (es)
MX (1) MXPA03008905A (es)
PA (1) PA8584101A1 (es)
WO (1) WO2004028272A2 (es)
ZA (1) ZA200306952B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
CA2566084C (en) * 2004-06-07 2014-01-21 Syngenta Participations Ag Methods of reducing nematode damage
WO2006007630A1 (en) * 2004-07-22 2006-01-26 Jurox Pty Ltd Aqueous insecticidal/parasiticide formulation
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
EP2452670A1 (en) * 2004-10-01 2012-05-16 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
WO2007071008A1 (en) * 2005-12-23 2007-06-28 Miv Therapeutics Inc. Compositions formulated for solvent-regulated drug release
US8313752B2 (en) * 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
KR101352867B1 (ko) * 2011-11-07 2014-01-21 주식회사 한동 동물용 복합항생제 조성물
CN104168886A (zh) * 2012-03-13 2014-11-26 拜耳新西兰有限公司 长效组合物
KR101458611B1 (ko) * 2012-08-02 2014-11-11 주식회사 한동 동물용 복합항생제 조성물
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
CN105078801B (zh) * 2014-05-12 2019-01-04 南京点元环境科技有限公司 一种绿色健康洗甲水
ES2483599B2 (es) 2014-05-26 2015-03-31 Sipcam Inagra, S.A. Composición Sinérgica Surfactante
CN104984334B (zh) * 2015-06-26 2018-06-26 金宇保灵生物药品有限公司 一种狂犬病弱毒苗-吡喹酮复合剂及其制备方法与应用
CN105746908B (zh) * 2016-02-23 2018-08-28 广州英赛特生物技术有限公司 肉豆蔻酸衍生物在制备动物生长促进剂中的应用
CN107375205B (zh) * 2017-07-31 2019-11-08 佛山市南海东方澳龙制药有限公司 非油性多拉菌素注射液及其制备方法和应用
US20220142972A1 (en) * 2018-12-21 2022-05-12 ELANCO US, Inc. Parasiticidal formulations and use thereof
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239345A (en) 1965-02-15 1966-03-08 Estrogenic compounds and animal growth promoters
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4778821A (en) 1987-07-15 1988-10-18 International Minerals & Chemical Corp. Method for controlling helmintic parasites
US5332577A (en) 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5288496A (en) 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
DE69229318T2 (de) 1991-09-30 1999-11-18 Merck & Co Inc Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
US5686092A (en) 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
ES2359973T3 (es) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant

Also Published As

Publication number Publication date
AU2003274415A8 (en) 2004-04-19
WO2004028272A3 (en) 2004-05-21
CN1684664A (zh) 2005-10-19
MXPA03008905A (es) 2005-10-05
ZA200306952B (en) 2005-02-23
ECSP055710A (es) 2005-08-11
CO5440227A1 (es) 2004-09-30
WO2004028272A2 (en) 2004-04-08
AU2003274415A1 (en) 2004-04-19
US6653288B1 (en) 2003-11-25

Similar Documents

Publication Publication Date Title
PA8584101A1 (es) Composicion antihelmintica e inyectable mejoradora de crecimiento
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
BR112014000178A2 (pt) composições tópicas
AR047608A1 (es) Composicion detergente liquida mejorada para usarse con un despachador generador de espuma
HN2001000273A (es) Metodos y composiciones para la proteccion de plantas y cultivos.
BRPI0408925A (pt) veìculos de fase simples não-aquosos e formulações utilizando tais veìculos
BRPI0502094A (pt) Composição, e, método
CR8428A (es) Agente endoparasiticidas para la administracion topica
FR3047901B1 (fr) Biomateriaux composites a liberation controlee de principe actif
PA8815301A1 (es) Ido5 antagonistas de pcsk9
BRPI0416038A (pt) gel baseado em tensoativo como um veìculo injetável de liberação sustentada de droga
AR058193A1 (es) Composiciones farmaceuticas
EA201892156A1 (ru) Система доставки
GT200000108A (es) Procedimiento para la obtencion de composiciones antibacteriales.
AR060152A1 (es) Agentes herbicidas en forma de dispersiones que contienen diflufenican y flurtamona
AR030947A1 (es) Guanidinas de acido cinamico substituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como un medicamento que las contiene
ATE427760T1 (de) Erodierbare polymere zur injektion
AR040205A1 (es) Composicion herbicida
ECSP055566A (es) Formulaciones de depósito de corta duración
CO5700779A2 (es) Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas
BRPI0519157A2 (pt) composiÇço, e, uso da mesma
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
EA201891847A1 (ru) Зародышеобразователь для твердых термопластичных полиуретанов
AR057648A1 (es) Composicion de metaflumizona para la administracion topica